http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-495332-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d669af06cb2abbcd6823699582a97002
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-26
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
filingDate 1969-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26178b78d3f4e0b8d9fd9902e691a501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19590d82af9c4851adb53f9f9ee5aee4
publicationDate 1970-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-495332-A
titleOfInvention Process for the preparation of aminoketones containing alkoxy groups
abstract Compounds of formula (I) their salts and quaternary ammonium derivatives are useful in the treatment of coronary insufficiency, myocardial infarct, myocardial insufficiency, angina pectoris and other heart or circulatory disorders and also migraine and arteriosclerosis. (where R2 and R3 = H, CH3O or NO2; Y = phenyl or a condensed ring aromatic group, one or more of the rings being partially or completely saturated; R4 = H, CH3 or C2H5; R5 and R6 = H or CH3; R7 = H or OH; R8 = OH or alkyl (2-6 C); R9 = H, OH or alkyl (2-6 C) one of R8 and R9 may also represent CH, when the other is OH, and R1 = -o-Alk-OH Alk alkylene of 1-6 C, opt. substd. by OH; R10 and R11 H or alkyl opt. unsatd.) or R10 and R11 opt. with the group Alk form a 5, 6 or 7 membered ring, opt. substd. by an alkyl, acyl, benzyl, oxyalkyl, alkoxyalkyl, acyloxyalkyl, ester or amide group, and opt. contg. another heteroatom e.g. O, S or N).
priorityDate 1963-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457531102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21864698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426123448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450805708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6931150

Total number of triples: 46.